These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 30252537)
21. Thiomers for oral delivery of hydrophilic macromolecular drugs. Bernkop-Schnürch A; Hoffer MH; Kafedjiiski K Expert Opin Drug Deliv; 2004 Nov; 1(1):87-98. PubMed ID: 16296722 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of in vitro enzymatic degradation of various thiomers and cross-linked thiomers. Kafedjiiski K; Föger F; Hoyer H; Bernkop-Schnürch A; Werle M Drug Dev Ind Pharm; 2007 Feb; 33(2):199-208. PubMed ID: 17454052 [TBL] [Abstract][Full Text] [Related]
23. Retrograded starch/pectin coated gellan gum-microparticles for oral administration of insulin: A technological platform for protection against enzymatic degradation and improvement of intestinal permeability. Meneguin AB; Beyssac E; Garrait G; Hsein H; Cury BSF Eur J Pharm Biopharm; 2018 Feb; 123():84-94. PubMed ID: 29175551 [TBL] [Abstract][Full Text] [Related]
24. Thiomers and thiomer-based nanoparticles in protein and DNA drug delivery. Hauptstein S; Bernkop-Schnürch A Expert Opin Drug Deliv; 2012 Sep; 9(9):1069-81. PubMed ID: 22703388 [TBL] [Abstract][Full Text] [Related]
25. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems. Hetényi G; Griesser J; Nardin I; Bernkop-Schnürch A Pharm Res; 2017 Jun; 34(6):1171-1179. PubMed ID: 28283859 [TBL] [Abstract][Full Text] [Related]
26. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of self nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin using hydrophobic complexation by cationic polymer of β-cyclodextrin. Soltani Y; Goodarzi N; Mahjub R Drug Dev Ind Pharm; 2017 Nov; 43(11):1899-1907. PubMed ID: 28685625 [TBL] [Abstract][Full Text] [Related]
28. Enhanced stability of oral insulin in targeted peptide ligand trimethyl chitosan nanoparticles against trypsin. Chen J; Liu C; Shan W; Xiao Z; Guo H; Huang Y J Microencapsul; 2015; 32(7):632-41. PubMed ID: 26401551 [TBL] [Abstract][Full Text] [Related]
29. Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(L-lactic acid): protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicity. Simon M; Behrens I; Dailey LA; Wittmar M; Kissel T Eur J Pharm Biopharm; 2007 May; 66(2):165-72. PubMed ID: 17150341 [TBL] [Abstract][Full Text] [Related]
30. Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates. Denora N; Lopedota A; Perrone M; Laquintana V; Iacobazzi RM; Milella A; Fanizza E; Depalo N; Cutrignelli A; Lopalco A; Franco M Acta Biomater; 2016 Oct; 43():170-184. PubMed ID: 27427225 [TBL] [Abstract][Full Text] [Related]
31. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. Wong CY; Al-Salami H; Dass CR J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133 [TBL] [Abstract][Full Text] [Related]
32. Enhanced oral insulin delivery via surface hydrophilic modification of chitosan copolymer based self-assembly polyelectrolyte nanocomplex. Liu C; Kou Y; Zhang X; Dong W; Cheng H; Mao S Int J Pharm; 2019 Jan; 554():36-47. PubMed ID: 30385377 [TBL] [Abstract][Full Text] [Related]
34. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Niu M; Lu Y; Hovgaard L; Wu W Int J Nanomedicine; 2011; 6():1155-66. PubMed ID: 21822379 [TBL] [Abstract][Full Text] [Related]
35. Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Karamanidou T; Karidi K; Bourganis V; Kontonikola K; Kammona O; Kiparissides C Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):223-9. PubMed ID: 25933940 [TBL] [Abstract][Full Text] [Related]
36. Stability effect of cholesterol-poly(acrylic acid) in a stimuli-responsive polymer-liposome complex obtained from soybean lecithin for controlled drug delivery. Simões MG; Alves P; Carvalheiro M; Simões PN Colloids Surf B Biointerfaces; 2017 Apr; 152():103-113. PubMed ID: 28088691 [TBL] [Abstract][Full Text] [Related]
37. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models. Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239 [TBL] [Abstract][Full Text] [Related]
38. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin. Sun W; Mao S; Mei D; Kissel T Eur J Pharm Biopharm; 2008 Jun; 69(2):417-25. PubMed ID: 18294825 [TBL] [Abstract][Full Text] [Related]
39. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. Krauland AH; Guggi D; Bernkop-Schnürch A J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465 [TBL] [Abstract][Full Text] [Related]
40. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates. Kavimandan NJ; Losi E; Peppas NA Biomaterials; 2006 Jul; 27(20):3846-54. PubMed ID: 16529810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]